This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: The Histone Deacetylase Inhibitor ITF2357 Decreases Surface CXCR4 and CCR5 Expression on CD4+ T-Cells and Monocytes and is Superior to Valproic Acid for Latent HIV-1 Expression in Vitro, JAIDS Journal of Acquired Immune Deficiency Syndromes, May 2010, Wolters Kluwer Health,
DOI: 10.1097/qai.0b013e3181d3dca3.
You can read the full text:
The following have contributed to this page
